Overview

Extension to Study HMR1964A/3011 in Belgium

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to allow patients to continue on HOE 901 until launch and to gather additional long-term safety data.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Insulin
Insulin Glargine